Status:
COMPLETED
Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension
Lead Sponsor:
Abbott
Conditions:
Hypertension
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
This study will investigate antihypertensive activity and safety profile of Tarka in Russian hypertension patients by ambulatory blood pressure measurement (ABPM)
Eligibility Criteria
Inclusion
- Hypertension
Exclusion
- SBP \> 180 mm Hg, DBP \> 114 mm Hg
- Subject has a hypersensitivity to trandolapril or verapamil
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00235001
Start Date
June 1 2004
Last Update
July 10 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Global Medical Information-Abbott
North Chicago, Illinois, United States, 60064